BDNF and Parkinson disease: Moreover, RBFOX1 dysregulation has been associated with intellectual disability, autism, epilepsy and Parkinson disease, pathologies that have been associated with alterations in BDNF signaling as well (Chao et al., 2006; Conboy, 2017; Lu et al., 2013).